This clinical trial, sponsored by the National Center for Complementary and Integrative Health (NCCIH), aimed to investigate potential adverse interactions between St. John's wort (SJW) and opioid medications (oxycodone and fentanyl) in healthy volunteers. The study focused on how SJW might affect the metabolism and efficacy of these opioids, which are commonly used for cancer pain management.